Current and historical daily PE Ratio for Getein Biotech Inc (
SHSE:603387
) from 2017 to Jun 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Getein Biotech stock (SHSE:603387) PE ratio as of Jun 25 2024 is 16.17.
More Details
Getein Biotech Inc (SHSE:603387) PE Ratio (TTM) Chart
Getein Biotech Inc (SHSE:603387) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 1211
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Getein Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-25 | 16.2 | 2024-04-17 | 18.1 |
| 2024-06-24 | 16.1 | 2024-04-16 | 17.1 |
| 2024-06-21 | 16.9 | 2024-04-15 | 17.9 |
| 2024-06-20 | 16.7 | 2024-04-12 | 18.5 |
| 2024-06-19 | 17.0 | 2024-04-11 | 19.0 |
| 2024-06-18 | 17.2 | 2024-04-10 | 19.2 |
| 2024-06-17 | 17.3 | 2024-04-09 | 19.7 |
| 2024-06-14 | 17.5 | 2024-04-08 | 18.8 |
| 2024-06-13 | 17.7 | 2024-04-03 | 19.6 |
| 2024-06-12 | 17.7 | 2024-04-02 | 19.4 |
| 2024-06-11 | 17.7 | 2024-04-01 | 19.6 |
| 2024-06-07 | 17.8 | 2024-03-29 | 19.2 |
| 2024-06-06 | 17.4 | 2024-03-28 | 19.0 |
| 2024-06-05 | 18.0 | 2024-03-27 | 16.9 |
| 2024-06-04 | 18.1 | 2024-03-26 | 16.4 |
| 2024-06-03 | 18.2 | 2024-03-25 | 16.2 |
| 2024-05-31 | 18.8 | 2024-03-22 | 16.7 |
| 2024-05-30 | 18.6 | 2024-03-21 | 17.0 |
| 2024-05-29 | 18.5 | 2024-03-20 | 17.1 |
| 2024-05-28 | 18.6 | 2024-03-19 | 17.2 |
| 2024-05-27 | 18.7 | 2024-03-18 | 16.8 |
| 2024-05-24 | 18.8 | 2024-03-15 | 16.4 |
| 2024-05-23 | 18.8 | 2024-03-14 | 16.4 |
| 2024-05-22 | 19.2 | 2024-03-13 | 16.4 |
| 2024-05-21 | 19.2 | 2024-03-12 | 16.5 |
| 2024-05-20 | 19.4 | 2024-03-11 | 16.1 |
| 2024-05-17 | 19.7 | 2024-03-08 | 15.7 |
| 2024-05-16 | 19.8 | 2024-03-07 | 15.7 |
| 2024-05-15 | 19.8 | 2024-03-06 | 15.9 |
| 2024-05-14 | 19.9 | 2024-03-05 | 16.0 |
| 2024-05-13 | 19.9 | 2024-03-04 | 16.4 |
| 2024-05-10 | 20.2 | 2024-03-01 | 16.4 |
| 2024-05-09 | 20.7 | 2024-02-29 | 16.4 |
| 2024-05-08 | 20.5 | 2024-02-28 | 16.1 |
| 2024-05-07 | 20.5 | 2024-02-27 | 17.1 |
| 2024-05-06 | 20.5 | 2024-02-26 | 16.8 |
| 2024-04-30 | 19.6 | 2024-02-23 | 16.8 |
| 2024-04-29 | 19.2 | 2024-02-22 | 16.6 |
| 2024-04-26 | 18.8 | 2024-02-21 | 16.4 |
| 2024-04-25 | 18.8 | 2024-02-20 | 16.2 |
| 2024-04-24 | 18.2 | 2024-02-19 | 16.2 |
| 2024-04-23 | 18.2 | 2024-02-08 | 15.8 |
| 2024-04-22 | 18.0 | 2024-02-07 | 14.6 |
| 2024-04-19 | 18.0 | 2024-02-06 | 14.6 |
| 2024-04-18 | 18.0 | 2024-02-05 | 14.1 |
Getein Biotech Inc (SHSE:603387) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Getein Biotech Inc
ISIN : CNE100002RR9
Share Class Description:
SHSE:603387: Class ACompare
Compare
Traded in other countries / regions
603387.China IPO Date
2017-07-17Description
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers